AKT2 and glioblastoma: (50) demonstrated that TTFields therapy up-regulates autophagy-related genes and induces cell morphological changes, and that TTFields-induced autophagy in glioblastoma is associated with reduced Akt2 expression via the mTOR/p70S6K pathway.